S Sridhar resigns as MD of Pfizer; To take early retirement

He will continue to serve in his current position until the identification, selection and transition to the new leadership takes place in the company, the company stated.

S Sridhar resigns as MD of Pfizer; To take early retirement
RSV is estimated to cause about 14,000 annual deaths among older adults in the United States. (File)

Drug firm Pfizer on Wednesday announced that its Managing Director S Sridhar has resigned from the company. According to reports, Sridhar has expressed his intention to take early retirement and has tendered his resignation, the company said in a regulatory filing.

He will continue to serve in his current position until the identification, selection and transition to the new leadership takes place in the company, the company stated.

Over the past 14 years, Sridhar has led a number of key leadership positions in Pfizer, including serving as the Chief Financial Officer for a period of eight years.

ALSO READ | Pfizer to buy 8.1 percent stake in French vaccines company Valneva

Over the past six years, he has led Pfizer as Managing Director and made significant contributions to the growth of the company’s portfolio and presence across India, the drug firm stated.

“Sridhar made a significant contribution to the growth of the company’s portfolio, presence across India and reach to patients who have benefited from access to Pfizer therapies,” the company said.

Moreover, Sridhar also serves as the President of the Organisation of Pharmaceuticals Producers of India (OPPI).

Get live Share Market updates and latest India News and business news on Financial Express. Download Financial Express App for latest business news.

Photos